Investor Presentation

30th June 2017 - 2:55 pm

ImmuPharma’s management team outlines the current status of the Lupuzor™ Phase III trial as well presenting on its ‘Nucants’ and ‘Peptide’ Platform. Vadim Alexandre, Northland Capital Partners’ Healthcare Analyst also gives a short presentation on ImmuPharma’s investment case.






To watch the video of the presentation please view here

Share this article